Announced
Completed
Financials
Tags
pharmaceuticals
Pharmaceuticals
Germany
Acquisition
Cross Border
Majority
Private
Completed
Friendly
Single Bidder
Synopsis
CCL Industries, a security and packaging solutions provider, completed the acquisition of Faubel, a pharmaceutical company, for $186m. "Clinical trials labeling has long been an important component of our North American Healthcare business. This acquisition adds organizational and operational capacity in Europe to build a global presence in the space. We have known and admired Faubel for more than 15 years and are very pleased to welcome their outstanding team to our Company. It will become an integral part of the global Healthcare & Specialty business led by Lee Pretsell, Group Vice President, who reports to Guenther Birkner, President - Healthcare & Specialty, Food & Beverage and Innovia," Geoffrey T. Martin, CCL Industries President & CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.